Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort

Aim:  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in vitro that lipids within hepatocytes are crucially important for a series of HCV infection–proliferation–release processes. On the other ha...

Full description

Saved in:
Bibliographic Details
Published inHepatology research Vol. 41; no. 6; pp. 530 - 541
Main Authors Miyazaki, Teruo, Honda, Akira, Ikegami, Tadashi, Saitoh, Yoshifumi, Hirayama, Takeshi, Hara, Takashi, Doy, Mikio, Matsuzaki, Yasushi
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim:  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in vitro that lipids within hepatocytes are crucially important for a series of HCV infection–proliferation–release processes. On the other hand, in the patients with HCV, the serum total cholesterol (Total‐C) and low‐density lipoprotein cholesterol (LDL‐C) levels have been reported to be lower. We conducted an epidemiological survey of a large cohort and investigated whether the lower serum lipid levels were caused by a direct or the secondary effects of HCV infection (i.e. hepatic damage or nutritional disorder). Methods:  Among 146 857 participants (male, 34%; female, 66%) undergoing public health examinations between 2002 and 2007 in Ibaraki Prefecture, Japan, the HCV positive rates determined by HCV antibody/antigen and/or RNA tests were 1.37% and 0.67% in males and females, respectively. Results:  In addition to Total‐C and LDL‐C, serum high‐density lipoprotein cholesterol and triglyceride concentrations were also significantly lower in the HCV positive subjects compared with the negative subjects, regardless of sex, age or nutritional state evaluated by body mass index. Multivariate analysis showed that HCV infection was the strongest among the factors to be significantly associated with the lower level of these lipids. Particularly, the hypolipidemia was also confirmed in the HCV positive subjects with normal aminotransferase levels (alanine aminotransferase ≤30 and aspartate aminotransferase ≤30). Conclusion:  This epidemiological survey in a large Japanese cohort suggests that the HCV infection itself might directly cause hypolipidemia, irrespective of host factors including age, hepatic damage and nutritional state.
AbstractList Aim:  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in vitro that lipids within hepatocytes are crucially important for a series of HCV infection–proliferation–release processes. On the other hand, in the patients with HCV, the serum total cholesterol (Total‐C) and low‐density lipoprotein cholesterol (LDL‐C) levels have been reported to be lower. We conducted an epidemiological survey of a large cohort and investigated whether the lower serum lipid levels were caused by a direct or the secondary effects of HCV infection (i.e. hepatic damage or nutritional disorder). Methods:  Among 146 857 participants (male, 34%; female, 66%) undergoing public health examinations between 2002 and 2007 in Ibaraki Prefecture, Japan, the HCV positive rates determined by HCV antibody/antigen and/or RNA tests were 1.37% and 0.67% in males and females, respectively. Results:  In addition to Total‐C and LDL‐C, serum high‐density lipoprotein cholesterol and triglyceride concentrations were also significantly lower in the HCV positive subjects compared with the negative subjects, regardless of sex, age or nutritional state evaluated by body mass index. Multivariate analysis showed that HCV infection was the strongest among the factors to be significantly associated with the lower level of these lipids. Particularly, the hypolipidemia was also confirmed in the HCV positive subjects with normal aminotransferase levels (alanine aminotransferase ≤30 and aspartate aminotransferase ≤30). Conclusion:  This epidemiological survey in a large Japanese cohort suggests that the HCV infection itself might directly cause hypolipidemia, irrespective of host factors including age, hepatic damage and nutritional state.
Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in vitro that lipids within hepatocytes are crucially important for a series of HCV infection-proliferation-release processes. On the other hand, in the patients with HCV, the serum total cholesterol (Total-C) and low-density lipoprotein cholesterol (LDL-C) levels have been reported to be lower. We conducted an epidemiological survey of a large cohort and investigated whether the lower serum lipid levels were caused by a direct or the secondary effects of HCV infection (i.e. hepatic damage or nutritional disorder).   Among 146 857 participants (male, 34%; female, 66%) undergoing public health examinations between 2002 and 2007 in Ibaraki Prefecture, Japan, the HCV positive rates determined by HCV antibody/antigen and/or RNA tests were 1.37% and 0.67% in males and females, respectively.   In addition to Total-C and LDL-C, serum high-density lipoprotein cholesterol and triglyceride concentrations were also significantly lower in the HCV positive subjects compared with the negative subjects, regardless of sex, age or nutritional state evaluated by body mass index. Multivariate analysis showed that HCV infection was the strongest among the factors to be significantly associated with the lower level of these lipids. Particularly, the hypolipidemia was also confirmed in the HCV positive subjects with normal aminotransferase levels (alanine aminotransferase ≤30 and aspartate aminotransferase ≤30).   This epidemiological survey in a large Japanese cohort suggests that the HCV infection itself might directly cause hypolipidemia, irrespective of host factors including age, hepatic damage and nutritional state.
AIM  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in vitro that lipids within hepatocytes are crucially important for a series of HCV infection-proliferation-release processes. On the other hand, in the patients with HCV, the serum total cholesterol (Total-C) and low-density lipoprotein cholesterol (LDL-C) levels have been reported to be lower. We conducted an epidemiological survey of a large cohort and investigated whether the lower serum lipid levels were caused by a direct or the secondary effects of HCV infection (i.e. hepatic damage or nutritional disorder). METHODS  Among 146 857 participants (male, 34%; female, 66%) undergoing public health examinations between 2002 and 2007 in Ibaraki Prefecture, Japan, the HCV positive rates determined by HCV antibody/antigen and/or RNA tests were 1.37% and 0.67% in males and females, respectively. RESULTS  In addition to Total-C and LDL-C, serum high-density lipoprotein cholesterol and triglyceride concentrations were also significantly lower in the HCV positive subjects compared with the negative subjects, regardless of sex, age or nutritional state evaluated by body mass index. Multivariate analysis showed that HCV infection was the strongest among the factors to be significantly associated with the lower level of these lipids. Particularly, the hypolipidemia was also confirmed in the HCV positive subjects with normal aminotransferase levels (alanine aminotransferase ≤30 and aspartate aminotransferase ≤30). CONCLUSION  This epidemiological survey in a large Japanese cohort suggests that the HCV infection itself might directly cause hypolipidemia, irrespective of host factors including age, hepatic damage and nutritional state.
Aim:  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in vitro that lipids within hepatocytes are crucially important for a series of HCV infection–proliferation–release processes. On the other hand, in the patients with HCV, the serum total cholesterol (Total‐C) and low‐density lipoprotein cholesterol (LDL‐C) levels have been reported to be lower. We conducted an epidemiological survey of a large cohort and investigated whether the lower serum lipid levels were caused by a direct or the secondary effects of HCV infection (i.e. hepatic damage or nutritional disorder). Methods:  Among 146 857 participants (male, 34%; female, 66%) undergoing public health examinations between 2002 and 2007 in Ibaraki Prefecture, Japan, the HCV positive rates determined by HCV antibody/antigen and/or RNA tests were 1.37% and 0.67% in males and females, respectively. Results:  In addition to Total‐C and LDL‐C, serum high‐density lipoprotein cholesterol and triglyceride concentrations were also significantly lower in the HCV positive subjects compared with the negative subjects, regardless of sex, age or nutritional state evaluated by body mass index. Multivariate analysis showed that HCV infection was the strongest among the factors to be significantly associated with the lower level of these lipids. Particularly, the hypolipidemia was also confirmed in the HCV positive subjects with normal aminotransferase levels (alanine aminotransferase ≤30 and aspartate aminotransferase ≤30). Conclusion:  This epidemiological survey in a large Japanese cohort suggests that the HCV infection itself might directly cause hypolipidemia, irrespective of host factors including age, hepatic damage and nutritional state.
Author Ikegami, Tadashi
Saitoh, Yoshifumi
Hirayama, Takeshi
Hara, Takashi
Miyazaki, Teruo
Honda, Akira
Doy, Mikio
Matsuzaki, Yasushi
Author_xml – sequence: 1
  givenname: Teruo
  surname: Miyazaki
  fullname: Miyazaki, Teruo
  organization: Department of Development for Community Medicine, Tokyo Medical University
– sequence: 2
  givenname: Akira
  surname: Honda
  fullname: Honda, Akira
  organization: Department of Development for Community Medicine, Tokyo Medical University
– sequence: 3
  givenname: Tadashi
  surname: Ikegami
  fullname: Ikegami, Tadashi
  organization: Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center
– sequence: 4
  givenname: Yoshifumi
  surname: Saitoh
  fullname: Saitoh, Yoshifumi
  organization: Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center
– sequence: 5
  givenname: Takeshi
  surname: Hirayama
  fullname: Hirayama, Takeshi
  organization: Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center
– sequence: 6
  givenname: Takashi
  surname: Hara
  fullname: Hara, Takashi
  organization: Ibaraki Prefectural Institute of Public Health, Mito
– sequence: 7
  givenname: Mikio
  surname: Doy
  fullname: Doy, Mikio
  organization: Ibaraki Prefectural Central Hospital, Kasama, Japan
– sequence: 8
  givenname: Yasushi
  surname: Matsuzaki
  fullname: Matsuzaki, Yasushi
  email: ymatsuzaki-gi@umin.ac.jp
  organization: Department of Development for Community Medicine, Tokyo Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21501354$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1u1DAUhS1URP94BeQdqwQ7TmwPEotq-jOgClDVquwsx7mZ8ZDEwU7KzJvwuDhNmTXe-Fr3fOda95yio851gBCmJKXxfNimVIosISz_kWaE0pQQSVi6e4VODo2jWDPJE85yfoxOQ9gSQgXJ8jfoOKMFoazIT9CfFfR6sIMNeImfrB8Dtl0NZrCuw0aPAQLe7HvX2N5W0FqNPay1rxoIAbsab55xgyvd6jVg53E3Dt5OuG5wGPQAH_FFh2HGXePW1kyd0T_BfnLQuNE-ol90rzsIgI3bOD-co9e1bgK8fbnP0MP11f1yldx-u_m8vLhNTJEVLKEszxiXJeOCVhVjmukFqUR8ypqRkmeCGkFLTalZZBKIjF1mZJkLonMWHc7Q-9m39-7XCGFQrQ0GmiZ-xo1BSS4XC54zEZVyVhrvQvBQq97bVvu9okRNsaitmravpu2rKRb1HIvaRfTdy5CxbKE6gP9yiIJPs-C3bWD_38ZqdfX9LlaRT2behgF2B177n4oLJgr1-PVG3V1fMnJJuCrYXzYCrlk
CitedBy_id crossref_primary_10_1016_S2222_1808_16_61166_0
crossref_primary_10_1186_s12876_018_0747_5
crossref_primary_10_1007_s11011_014_9520_9
crossref_primary_10_1007_s00281_012_0356_2
crossref_primary_10_3390_metabo11050273
crossref_primary_10_3748_wjg_v21_i36_10299
crossref_primary_10_2169_internalmedicine_9479_17
crossref_primary_10_1007_s00535_012_0610_3
crossref_primary_10_1097_QAD_0b013e3283528b1c
crossref_primary_10_12998_wjcc_v2_i7_240
crossref_primary_10_1590_s0102_67202015000200012
crossref_primary_10_1016_j_jhep_2024_01_030
crossref_primary_10_3109_08880018_2013_825355
crossref_primary_10_1111_j_1872_034X_2011_00838_x
crossref_primary_10_1007_s12072_015_9629_x
crossref_primary_10_1016_j_bbrc_2014_01_176
Cites_doi 10.1016/S1286-4579(02)01649-0
10.1038/ncb1631
10.1001/archinte.1997.00440280120012
10.1016/S0168-8278(99)80154-8
10.1016/j.tim.2005.02.004
10.1093/ajcn/55.2.488s
10.1159/000087271
10.1099/vir.0.82033-0
10.1111/j.1365-2893.2005.00655.x
10.1046/j.1365-2893.1999.6120139.x
10.1016/S0009-8981(97)06532-7
10.1136/gut.19.6.526
10.1099/vir.0.008300-0
10.1016/S0962-8924(02)02383-8
10.1016/j.cgh.2006.02.002
10.1016/j.clinbiochem.2004.03.008
10.1002/hep.23219
10.1159/000150360
10.1053/jhep.2002.35530
10.1002/hep.21261
10.1136/gut.2006.091983
10.1111/j.1572-0241.2002.07056.x
10.1111/j.1748-720X.1991.tb01822.x
10.1016/S0168-8278(00)00036-2
10.1096/fj.01-0396com
10.1128/JVI.01150-06
10.1073/pnas.96.22.12766
10.1086/506440
10.1053/jhep.2001.24432
10.1089/apc.2006.0150
10.1016/j.jhep.2008.03.016
10.1073/pnas.0700760104
10.1136/gut.51.4.585
10.1053/j.gastro.2004.11.016
10.1128/JVI.02053-07
10.1093/clinchem/18.6.499
10.1111/j.1872-034X.2007.00217.x
10.1128/JVI.76.14.6919-6928.2002
10.1053/jhep.2002.36386
10.1111/j.1872-034X.2009.00513.x
10.1194/jlr.D800017-JLR200
10.1086/599371
ContentType Journal Article
Copyright 2011 The Japan Society of Hepatology
2011 The Japan Society of Hepatology.
Copyright_xml – notice: 2011 The Japan Society of Hepatology
– notice: 2011 The Japan Society of Hepatology.
DBID BSCLL
NPM
AAYXX
CITATION
7X8
DOI 10.1111/j.1872-034X.2011.00803.x
DatabaseName Istex
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-034X
EndPage 541
ExternalDocumentID 10_1111_j_1872_034X_2011_00803_x
21501354
HEPR803
ark_67375_WNG_RFD30D06_5
Genre article
Journal Article
GroupedDBID ---
--K
.3N
.GA
.Y3
05W
0R~
10A
1B1
1OC
1~5
29I
31~
33P
3SF
4.4
4G.
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AAJUZ
AALRI
AANLZ
AAONW
AAQFI
AAQXK
AASGY
AAVGM
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABCVL
ABDBF
ABEML
ABHUG
ABIJN
ABJNI
ABPTK
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIUM
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEQTP
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFVGU
AFZJQ
AGJLS
AHBTC
AIACR
AIAGR
AITUG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FDB
FEDTE
FGOYB
FUBAC
G-Q
G-S
G.N
GODZA
H.X
HF~
HVGLF
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NQ-
O66
O9-
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
R2-
RIG
ROL
RPZ
RX1
SEW
SSZ
SUPJJ
TEORI
TUS
UB1
UHS
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
ZZTAW
~IA
~WT
AITYG
HGLYW
OIG
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c5253-1342368b3671dd33a3a90d73678f30b6271c71ba11c928e0890d3c8b470a43253
IEDL.DBID DR2
ISSN 1386-6346
IngestDate Sat Aug 17 02:02:30 EDT 2024
Fri Aug 23 03:18:29 EDT 2024
Sat Sep 28 07:59:33 EDT 2024
Sat Aug 24 01:05:43 EDT 2024
Wed Jan 17 05:00:55 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License 2011 The Japan Society of Hepatology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5253-1342368b3671dd33a3a90d73678f30b6271c71ba11c928e0890d3c8b470a43253
Notes istex:6E458BFD01EBD13BDDABFEA3FD16EFDB04D82FA9
ArticleID:HEPR803
ark:/67375/WNG-RFD30D06-5
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21501354
PQID 868996437
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_868996437
crossref_primary_10_1111_j_1872_034X_2011_00803_x
pubmed_primary_21501354
wiley_primary_10_1111_j_1872_034X_2011_00803_x_HEPR803
istex_primary_ark_67375_WNG_RFD30D06_5
PublicationCentury 2000
PublicationDate June 2011
PublicationDateYYYYMMDD 2011-06-01
PublicationDate_xml – month: 06
  year: 2011
  text: June 2011
PublicationDecade 2010
PublicationPlace Melbourne, Australia
PublicationPlace_xml – name: Melbourne, Australia
– name: Netherlands
PublicationTitle Hepatology research
PublicationTitleAlternate Hepatol Res
PublicationYear 2011
Publisher Blackwell Publishing Asia
Publisher_xml – name: Blackwell Publishing Asia
References Huang H, Sun F, Owen DM et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 2007; 104: 5848-53.
Burlone ME, Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol 2009; 90: 1055-70.
Maggi G, Bottelli R, Gola D et al. Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol 1996; 28: 436-40.
McIntyre N. Plasma lipids and lipoproteins in liver disease. Gut 1978; 19: 526-30.
Sakurabayashi I, Kumasaka K. Laboratory Medicine Encyclopedia & Dictionary, 1st edn. Tokyo: Ishiyaku Publishers, Inc, 2008.
Floris-Moore M, Howard AA, Lo Y, Schoenbaum EE, Arnsten JH, Klein RS. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS 2007; 21: 479-91.
Renou C, Halfon P, Pol S et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 2002; 51: 585-90.
Honda A, Yamashita K, Miyazaki H et al. Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS. J Lipid Res 2008; 49: 2063-73.
Dharancy S, Malapel M, Perlemuter G et al. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 2005; 128: 334-42.
Miyanari Y, Atsuzawa K, Usuda N et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007; 9: 1089-97.
Miyazaki T, Honda A, Ikegami T et al. The associated markers and their limitations for the primary screening of HCV carriers in public health examination. Hepatol Res 2009; 39: 664-74.
Dai CY, Chuang WL, Ho CK et al. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol 2008; 49: 9-16.
Chuang WL, Yu ML, Dai CY, Chang WY. Treatment of chronic hepatitis C in southern Taiwan. Intervirology 2006; 49: 99-106.
Tardif KD, Waris G, Siddiqui A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 2005; 13: 159-63.
Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001; 34: 428-34.
Gopal K, Johnson TC, Gopal S et al. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment. Hepatology 2006; 44: 335-40.
Diaz O, Delers F, Maynard M et al. Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol 2006; 87: 2983-91.
Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 1999; 96: 12766-71.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
International guidelines for ethical review of epidemiological studies. Law Med Health Care 1991; 19: 247-58.
Ikegami T, Honda A, Nakamuta M et al. Non-invasive measurement of cholesterol metabolism in patients with HCV infection by using serum marker sterols. Hepatology 2009; 50: 946A-7A.
Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009; 49: 225-32.
Siagris D, Christofidou M, Theocharis GJ et al. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat 2006; 13: 56-61.
Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997; 157: 792-6.
Tremblay AJ, Morrissette H, Gagne JM, Bergeron J, Gagne C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004; 37: 785-90.
Andre P, Komurian-Pradel F, Deforges S et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002; 76: 6919-28.
Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-64.
Pradat P, Alberti A, Poynard T et al. Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology 2002; 36: 973-7.
Bray GA. Pathophysiology of obesity. Am J Clin Nutr 1992; 55: 488S-94S.
Dubuisson J, Penin F, Moradpour D. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol 2002; 12: 517-23.
Okanoue T, Itoh Y, Minami M et al. Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts. Hepatol Res 2008; 38: 27-36.
Bacon BR. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology 2002; 36: S179-84.
Marzouk D, Sass J, Bakr I et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut 2007; 56: 1105-10.
Shiffman ML, Diago M, Tran A et al. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol 2006; 4: 645-52.
Tassopoulos NC. EASL international consensus conference on hepatitis C Paris, 26-28 February 1999: consensus statement. J Hepatol 1999; 30: 956-61.
Sanchez-Conde M, Berenguer J, Miralles P et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis 2006; 43: 640-4.
Okamoto H, Mishiro S. Genetic heterogeneity of hepatitis C virus. Intervirology 1994; 37: 68-76.
Fabris C, Federico E, Soardo G, Falleti E, Pirisi M. Blood lipids of patients with chronic hepatitis: differences related to viral etiology. Clin Chim Acta 1997; 261: 159-65.
Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, Chisari FV. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 2008; 82: 2120-9.
Hofer H, Bankl HC, Wrba F et al. Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterol 2002; 97: 2880-5.
Gastaminza P, Kapadia SB, Chisari FV. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 2006; 80: 11074-81.
Perlemuter G, Sabile A, Letteron P et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002; 16: 185-94.
Japan Atherosclerosis Society. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases. J Atheroscler Thromb 2007: 5-57.
Corey KE, Kane E, Munroe C, Barlow LL, Zheng H, Chung RT. Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology 2009; 50: 1030-7.
Ray Kim W. Global epidemiology and burden of hepatitis C. Microbes Infect 2002; 4: 1219-25.
1997; 157
2002; 16
2007; 104
2002; 36
1991; 19
2006; 13
2002; 97
2002; 51
2002; 12
2002; 76
2008; 38
1978; 19
2008
2007
2002; 4
2006; 4
1999; 6
1992; 55
2007; 56
2009; 49
2006; 80
1996; 28
2006; 87
2009; 50
1997; 261
2006; 43
2006; 44
2006; 49
2004; 37
2009; 90
2008; 49
2005; 128
2007; 9
1999; 96
1999; 30
1994; 37
2001; 33
2007; 21
2001; 34
2008; 82
1972; 18
2005; 13
2009; 39
e_1_2_6_31_2
e_1_2_6_30_2
e_1_2_6_18_2
Ikegami T (e_1_2_6_47_2) 2009; 50
e_1_2_6_19_2
e_1_2_6_12_2
e_1_2_6_35_2
e_1_2_6_13_2
Maggi G (e_1_2_6_17_2) 1996; 28
e_1_2_6_34_2
e_1_2_6_10_2
e_1_2_6_33_2
e_1_2_6_11_2
e_1_2_6_32_2
e_1_2_6_16_2
e_1_2_6_39_2
e_1_2_6_38_2
e_1_2_6_14_2
e_1_2_6_37_2
e_1_2_6_15_2
e_1_2_6_36_2
e_1_2_6_42_2
e_1_2_6_20_2
e_1_2_6_41_2
Sakurabayashi I (e_1_2_6_28_2) 2008
e_1_2_6_40_2
e_1_2_6_8_2
e_1_2_6_7_2
Japan Atherosclerosis Society (e_1_2_6_29_2) 2007
e_1_2_6_9_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_21_2
e_1_2_6_43_2
e_1_2_6_27_2
e_1_2_6_44_2
e_1_2_6_26_2
e_1_2_6_45_2
e_1_2_6_25_2
e_1_2_6_46_2
References_xml – volume: 6
  start-page: 35
  year: 1999
  end-page: 47
– volume: 82
  start-page: 2120
  year: 2008
  end-page: 9
  article-title: Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion
  publication-title: J Virol
– volume: 19
  start-page: 247
  year: 1991
  end-page: 58
  article-title: International guidelines for ethical review of epidemiological studies
  publication-title: Law Med Health Care
– volume: 37
  start-page: 785
  year: 2004
  end-page: 90
  article-title: Validation of the Friedewald formula for the determination of low‐density lipoprotein cholesterol compared with beta‐quantification in a large population
  publication-title: Clin Biochem
– volume: 36
  start-page: 973
  year: 2002
  end-page: 7
  article-title: Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study
  publication-title: Hepatology
– volume: 39
  start-page: 664
  year: 2009
  end-page: 74
  article-title: The associated markers and their limitations for the primary screening of HCV carriers in public health examination
  publication-title: Hepatol Res
– start-page: 5
  year: 2007
  end-page: 57
  article-title: Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases
  publication-title: J Atheroscler Thromb
– volume: 56
  start-page: 1105
  year: 2007
  end-page: 10
  article-title: Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt
  publication-title: Gut
– volume: 13
  start-page: 159
  year: 2005
  end-page: 63
  article-title: Hepatitis C virus, ER stress, and oxidative stress
  publication-title: Trends Microbiol
– volume: 261
  start-page: 159
  year: 1997
  end-page: 65
  article-title: Blood lipids of patients with chronic hepatitis: differences related to viral etiology
  publication-title: Clin Chim Acta
– volume: 38
  start-page: 27
  year: 2008
  end-page: 36
  article-title: Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
  publication-title: Hepatol Res
– volume: 19
  start-page: 526
  year: 1978
  end-page: 30
  article-title: Plasma lipids and lipoproteins in liver disease
  publication-title: Gut
– volume: 90
  start-page: 1055
  year: 2009
  end-page: 70
  article-title: Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
  publication-title: J Gen Virol
– volume: 43
  start-page: 640
  year: 2006
  end-page: 4
  article-title: Liver biopsy findings for HIV‐infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase
  publication-title: Clin Infect Dis
– volume: 36
  start-page: S179
  year: 2002
  end-page: 84
  article-title: Treatment of patients with hepatitis C and normal serum aminotransferase levels
  publication-title: Hepatology
– volume: 97
  start-page: 2880
  year: 2002
  end-page: 5
  article-title: Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV‐3a
  publication-title: Am J Gastroenterol
– volume: 104
  start-page: 5848
  year: 2007
  end-page: 53
  article-title: Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low‐density lipoproteins
  publication-title: Proc Natl Acad Sci USA
– volume: 33
  start-page: 1358
  year: 2001
  end-page: 64
  article-title: Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
  publication-title: Hepatology
– volume: 4
  start-page: 1219
  year: 2002
  end-page: 25
  article-title: Global epidemiology and burden of hepatitis C
  publication-title: Microbes Infect
– volume: 49
  start-page: 9
  year: 2008
  end-page: 16
  article-title: Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community‐based study
  publication-title: J Hepatol
– volume: 76
  start-page: 6919
  year: 2002
  end-page: 28
  article-title: Characterization of low‐ and very‐low‐density hepatitis C virus RNA‐containing particles
  publication-title: J Virol
– volume: 12
  start-page: 517
  year: 2002
  end-page: 23
  article-title: Interaction of hepatitis C virus proteins with host cell membranes and lipids
  publication-title: Trends Cell Biol
– volume: 157
  start-page: 792
  year: 1997
  end-page: 6
  article-title: Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis
  publication-title: Arch Intern Med
– volume: 128
  start-page: 334
  year: 2005
  end-page: 42
  article-title: Impaired expression of the peroxisome proliferator‐activated receptor alpha during hepatitis C virus infection
  publication-title: Gastroenterology
– volume: 44
  start-page: 335
  year: 2006
  end-page: 40
  article-title: Correlation between beta‐lipoprotein levels and outcome of hepatitis C treatment
  publication-title: Hepatology
– volume: 96
  start-page: 12766
  year: 1999
  end-page: 71
  article-title: Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
  publication-title: Proc Natl Acad Sci USA
– volume: 34
  start-page: 428
  year: 2001
  end-page: 34
  article-title: Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
  publication-title: J Hepatol
– volume: 49
  start-page: 225
  year: 2009
  end-page: 32
  article-title: Hepatitis C virus infection and the risk of coronary disease
  publication-title: Clin Infect Dis
– year: 2008
– volume: 37
  start-page: 68
  year: 1994
  end-page: 76
  article-title: Genetic heterogeneity of hepatitis C virus
  publication-title: Intervirology
– volume: 49
  start-page: 99
  year: 2006
  end-page: 106
  article-title: Treatment of chronic hepatitis C in southern Taiwan
  publication-title: Intervirology
– volume: 50
  start-page: 946A
  year: 2009
  end-page: 7A
  article-title: Non‐invasive measurement of cholesterol metabolism in patients with HCV infection by using serum marker sterols
  publication-title: Hepatology
– volume: 28
  start-page: 436
  year: 1996
  end-page: 40
  article-title: Serum cholesterol and chronic hepatitis C
  publication-title: Ital J Gastroenterol
– volume: 80
  start-page: 11074
  year: 2006
  end-page: 81
  article-title: Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles
  publication-title: J Virol
– volume: 30
  start-page: 956
  year: 1999
  end-page: 61
  article-title: EASL international consensus conference on hepatitis C Paris, 26–28 February 1999: consensus statement
  publication-title: J Hepatol
– volume: 55
  start-page: 488S
  year: 1992
  end-page: 94S
  article-title: Pathophysiology of obesity
  publication-title: Am J Clin Nutr
– volume: 4
  start-page: 645
  year: 2006
  end-page: 52
  article-title: Chronic hepatitis C in patients with persistently normal alanine transaminase levels
  publication-title: Clin Gastroenterol Hepatol
– volume: 49
  start-page: 2063
  year: 2008
  end-page: 73
  article-title: Highly sensitive analysis of sterol profiles in human serum by LC‐ESI‐MS/MS
  publication-title: J Lipid Res
– volume: 87
  start-page: 2983
  year: 2006
  end-page: 91
  article-title: Preferential association of Hepatitis C virus with apolipoprotein B48‐containing lipoproteins
  publication-title: J Gen Virol
– volume: 13
  start-page: 56
  year: 2006
  end-page: 61
  article-title: Serum lipid pattern in chronic hepatitis C: histological and virological correlations
  publication-title: J Viral Hepat
– volume: 16
  start-page: 185
  year: 2002
  end-page: 94
  article-title: Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis
  publication-title: FASEB J
– volume: 50
  start-page: 1030
  year: 2009
  end-page: 7
  article-title: Hepatitis C virus infection and its clearance alter circulating lipids: implications for long‐term follow‐up
  publication-title: Hepatology
– volume: 18
  start-page: 499
  year: 1972
  end-page: 502
  article-title: Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin Chem
– volume: 9
  start-page: 1089
  year: 2007
  end-page: 97
  article-title: The lipid droplet is an important organelle for hepatitis C virus production
  publication-title: Nat Cell Biol
– volume: 51
  start-page: 585
  year: 2002
  end-page: 90
  article-title: Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels
  publication-title: Gut
– volume: 21
  start-page: 479
  year: 2007
  end-page: 91
  article-title: Hepatitis C infection is associated with lower lipids and high‐sensitivity C‐reactive protein in HIV‐infected men
  publication-title: AIDS Patient Care STDS
– start-page: 5
  year: 2007
  ident: e_1_2_6_29_2
  article-title: Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases
  publication-title: J Atheroscler Thromb
  contributor:
    fullname: Japan Atherosclerosis Society
– ident: e_1_2_6_3_2
  doi: 10.1016/S1286-4579(02)01649-0
– ident: e_1_2_6_9_2
  doi: 10.1038/ncb1631
– ident: e_1_2_6_22_2
  doi: 10.1001/archinte.1997.00440280120012
– volume: 50
  start-page: 946A
  year: 2009
  ident: e_1_2_6_47_2
  article-title: Non‐invasive measurement of cholesterol metabolism in patients with HCV infection by using serum marker sterols
  publication-title: Hepatology
  contributor:
    fullname: Ikegami T
– ident: e_1_2_6_23_2
  doi: 10.1016/S0168-8278(99)80154-8
– ident: e_1_2_6_44_2
  doi: 10.1016/j.tim.2005.02.004
– ident: e_1_2_6_30_2
  doi: 10.1093/ajcn/55.2.488s
– ident: e_1_2_6_41_2
  doi: 10.1159/000087271
– ident: e_1_2_6_6_2
  doi: 10.1099/vir.0.82033-0
– ident: e_1_2_6_16_2
  doi: 10.1111/j.1365-2893.2005.00655.x
– ident: e_1_2_6_2_2
  doi: 10.1046/j.1365-2893.1999.6120139.x
– ident: e_1_2_6_19_2
  doi: 10.1016/S0009-8981(97)06532-7
– ident: e_1_2_6_21_2
  doi: 10.1136/gut.19.6.526
– ident: e_1_2_6_7_2
  doi: 10.1099/vir.0.008300-0
– ident: e_1_2_6_8_2
  doi: 10.1016/S0962-8924(02)02383-8
– ident: e_1_2_6_25_2
  doi: 10.1016/j.cgh.2006.02.002
– ident: e_1_2_6_27_2
  doi: 10.1016/j.clinbiochem.2004.03.008
– ident: e_1_2_6_15_2
  doi: 10.1002/hep.23219
– ident: e_1_2_6_40_2
  doi: 10.1159/000150360
– ident: e_1_2_6_34_2
  doi: 10.1053/jhep.2002.35530
– ident: e_1_2_6_42_2
  doi: 10.1002/hep.21261
– ident: e_1_2_6_18_2
  doi: 10.1136/gut.2006.091983
– ident: e_1_2_6_38_2
  doi: 10.1111/j.1572-0241.2002.07056.x
– ident: e_1_2_6_31_2
  doi: 10.1111/j.1748-720X.1991.tb01822.x
– volume-title: Laboratory Medicine Encyclopedia & Dictionary
  year: 2008
  ident: e_1_2_6_28_2
  contributor:
    fullname: Sakurabayashi I
– ident: e_1_2_6_37_2
  doi: 10.1016/S0168-8278(00)00036-2
– volume: 28
  start-page: 436
  year: 1996
  ident: e_1_2_6_17_2
  article-title: Serum cholesterol and chronic hepatitis C
  publication-title: Ital J Gastroenterol
  contributor:
    fullname: Maggi G
– ident: e_1_2_6_43_2
  doi: 10.1096/fj.01-0396com
– ident: e_1_2_6_11_2
  doi: 10.1128/JVI.01150-06
– ident: e_1_2_6_5_2
  doi: 10.1073/pnas.96.22.12766
– ident: e_1_2_6_33_2
  doi: 10.1086/506440
– ident: e_1_2_6_39_2
  doi: 10.1053/jhep.2001.24432
– ident: e_1_2_6_36_2
  doi: 10.1089/apc.2006.0150
– ident: e_1_2_6_14_2
  doi: 10.1016/j.jhep.2008.03.016
– ident: e_1_2_6_10_2
  doi: 10.1073/pnas.0700760104
– ident: e_1_2_6_35_2
  doi: 10.1136/gut.51.4.585
– ident: e_1_2_6_45_2
  doi: 10.1053/j.gastro.2004.11.016
– ident: e_1_2_6_12_2
  doi: 10.1128/JVI.02053-07
– ident: e_1_2_6_26_2
  doi: 10.1093/clinchem/18.6.499
– ident: e_1_2_6_32_2
  doi: 10.1111/j.1872-034X.2007.00217.x
– ident: e_1_2_6_4_2
  doi: 10.1128/JVI.76.14.6919-6928.2002
– ident: e_1_2_6_24_2
  doi: 10.1053/jhep.2002.36386
– ident: e_1_2_6_20_2
  doi: 10.1111/j.1872-034X.2009.00513.x
– ident: e_1_2_6_46_2
  doi: 10.1194/jlr.D800017-JLR200
– ident: e_1_2_6_13_2
  doi: 10.1086/599371
SSID ssj0017024
Score 2.0760968
Snippet Aim:  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown...
Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in...
Aim:  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown...
AIM  Infection with hepatitis C virus (HCV) is the leading cause of liver cirrhosis that develops into hepatocellular carcinoma. Previous studies have shown in...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 530
SubjectTerms health examination
high-density lipoprotein cholesterol
low-density lipoprotein cholesterol
total cholesterol
triglyceride
Title Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort
URI https://api.istex.fr/ark:/67375/WNG-RFD30D06-5/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1872-034X.2011.00803.x
https://www.ncbi.nlm.nih.gov/pubmed/21501354
https://search.proquest.com/docview/868996437
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkRAX3o_w0hwQt6yc2I5dblXbZVWpFVpRsTfLThxabcmiPKqWX8LPZSbJLizqASFuiRJP4vGM_dkez8fY24SbIBy2QEl769KkZexl6WIuJJc-z0vV86ccn2SzU3m0UIsx_onOwgz5ITYLbuQZfX9NDu58s-3kRqckdDFm4kTwIyaEJymvHuGj-SaTVKL5yG9rsjgTMtsO6rlR0NZIdZuUfnUTDN1Gtf2wNL3PlusKDdEoy0nX-kn-_Y9cj_-nxg_YvRG9wt5gbg_ZrVA9YneOx_35x-zHLFCEdnvewD5cntddA-torwpy1zWhgbNrIoYYiGkd1OEL2ugF9rewKuGsL55D4b5iPwerGqo1WwB-tj_89B72Kgi_eG3JyKDp6stwTRIcXFBsOxwhCCByTSAG4Lp9wk6nh5_2Z_HI_RDnKlUiTigzYWa8yHRSFEI44XZ5ofHWlIL7LNVJrhPvkiTfTU3gBp-K3HipuZMCJTxlO9WqCs8ZFIXCV5wWqfdSldwVDqUXiExCEFq5iCXrdrbfhhQf9repEarcksotqdz2KrdXEXvXG8SmgKuXFCKnlf188sHOpweCH_DMqojB2mIsOi7txmDtV11jTYZTXdo2jdizwZI2whCGITJXMmJZbw9__Vt2dvhxjlcv_rXgS3Z3WDSnZaZXbKetu_AaUVfr3_T-9BNohR4h
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQKwEXKO8ABR8Qt6yc-JGUW9XtEkp3hVat2JtlJw6tumRRHlXLL-HnMpPHwqIeEOKWKPEkHs_Yn-3xfIS8CVjsuIEWyHFvXcRh7luRG59xwYRN01y2_CnTmUpOxdFCLno6IDwL0-WHWC-4oWe0_TU6OC5Ib3p5HIUoddGn4gT0w0cAKLfB-yV66Xi-ziUVRKxnuI2Vr7hQm2E9N0raGKu2Ue1XNwHRTVzbDkyT-2Q5VKmLR7kYNbUdpd__yPb4n-q8Q-71AJbudxb3gNxyxUNye9pv0T8iPxKHQdr1eUUP6OV52VR0CPgqaGqaylX07Bq5ITpuWkNL9wXMdAldLl3l9KwtntLMfIWujq5KWgyEAfDZ9vzTO7pfUPeL2hbtjFZNeemuUYKhSwxvp0eAA5BfkyIJcFk_JqeTw5ODxO_pH_xUhpL7ASYnVLHlKgqyjHPDzR7LIriNc86sCqMgjQJrgiDdC2PHYnjK09iKiBnBQcITslWsCveM0CyT8IqJeGitkDkzmQHpGYAT53gkjUeCoaH1ty7Lh_5tdgQq16hyjSrXrcr1lUfethaxLmDKC4ySi6T-PHuv55MxZ2OmtPQIHUxGg-_ihgzUftVUOlYw28WdU4887UxpLQyQGIBzKTyiWoP469_SyeGnOVw9_9eCr8md5GR6rI8_zD6-IHe7NXRcdXpJtuqycbsAwmr7qnWun1wmIkE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQK1VceD_C0wfELSsnfsTlVnW7LIWuqhUVe7PsxKHVlmyVR9XyS_i5zOSxsKgHhLglSjyJxzP2Z3s8HyFvIqY9t9ACOe6tCx3noRO5DRkXTLg0zWXLn3I0U9MTcbiQiz7-Cc_CdPkh1gtu6Bltf40OfpHlm06ukxiFLvpMnAB--Ajw5LZQPMaJ2Hi-TiUVJawnuNUqVFyozaieGyVtDFXbqPWrm3DoJqxtx6XJXbIcatSFoyxHTe1G6fc_kj3-nyrfI3d6-Er3Onu7T2754gHZOeo36B-SH1OPIdr1WUX36eVZ2VR0CPcqaGqbylf09BqZITpmWktL_xWM9Bw6XLrK6WlbPKWZ_QYdHV2VtBjoAuCz7emnd3SvoP4XsS1aGa2a8tJfowRLzzG4nR4CCkB2TYoUwGX9iJxMDj7vT8Oe_CFMZSx5GGFqQqUdV0mUZZxbbndZlsCtzjlzKk6iNImcjaJ0N9aeaXjKU-1EwqzgIOEx2SpWhX9KaJZJeMUmPHZOyJzZzIL0DKCJ9zyRNiDR0M7mosvxYX6bG4HKDarcoMpNq3JzFZC3rUGsC9hyiTFyiTRfZu_NfDLmbMyUkQGhg8UY8FzcjoHar5rKaAVzXdw3DciTzpLWwgCHATSXIiCqtYe__i0zPTiew9Wzfy34muwcjyfm04fZx-fkdreAjktOL8hWXTb-JSCw2r1qXesnyuwg8A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatitis+C+virus+infection+causes+hypolipidemia+regardless+of+hepatic+damage+or+nutritional+state%3A+An+epidemiological+survey+of+a+large+Japanese+cohort&rft.jtitle=Hepatology+research&rft.au=Miyazaki%2C+Teruo&rft.au=Honda%2C+Akira&rft.au=Ikegami%2C+Tadashi&rft.au=Saitoh%2C+Yoshifumi&rft.date=2011-06-01&rft.issn=1386-6346&rft.eissn=1872-034X&rft.volume=41&rft.issue=6&rft.spage=530&rft.epage=541&rft_id=info:doi/10.1111%2Fj.1872-034X.2011.00803.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1872_034X_2011_00803_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1386-6346&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1386-6346&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1386-6346&client=summon